Negócios · 03/08/19991 min de leitura
Agency Information Collection Activities; Announcement of OMB Approval; Survey of Licensed Biologics Manufacturers and Registered Blood Establishments for Year 2000 Compliance
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Survey of Licensed Biologics Manufacturers and Registered Blood Establishments for Year 2000 Compliance'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.